These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12428082)

  • 1. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance.
    McKee SA; Sane DC; Deliargyris EN
    Thromb Haemost; 2002 Nov; 88(5):711-5. PubMed ID: 12428082
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin resistance: myth or major problem?
    Grove EL; Hvas AM; Kristensen SD
    Scand J Clin Lab Invest; 2008; 68(4):257-9. PubMed ID: 18612918
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terms and conditions: semantic complexity and aspirin resistance.
    Hennekens CH; Schror K; Weisman S; FitzGerald GA
    Circulation; 2004 Sep; 110(12):1706-8. PubMed ID: 15381661
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug insight: aspirin resistance--fact or fashion?
    Patrono C; Rocca B
    Nat Clin Pract Cardiovasc Med; 2007 Jan; 4(1):42-50. PubMed ID: 17180149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cationic propyl gallate and adenosine diphosphate for the measurement of aspirin effectivity with optical aggregometry.
    Motovska Z; Sujanova Z; Wimmerova S; Ardo J; Skrakova M; Widimsky P
    Transl Res; 2007 Oct; 150(4):246-52. PubMed ID: 17900512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of aspirin resistance.
    Goodman T; Sharma P; Ferro A
    Int J Clin Pract; 2007 May; 61(5):826-34. PubMed ID: 17391325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric-coated aspirin: review shows similar inhibition of platelet aggregation to ordinary dispersible aspirin.
    Cardiovasc J S Afr; 2007; 18(1):41, 43. PubMed ID: 17392997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylsalicylic acid resistance--clinical diagnosis with unclear mechanism].
    Hillarp A
    Lakartidningen; 2004 Nov; 101(45):3504-6, 3508-9. PubMed ID: 15575422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PlA2 polymorphism and efficacy of aspirin.
    Cooke GE; Bray PF; Hamlington JD; Pham DM; Goldschmidt-Clermont PJ
    Lancet; 1998 Apr; 351(9111):1253. PubMed ID: 9643753
    [No Abstract]   [Full Text] [Related]  

  • 11. Aspirin resistance: what, why and when?
    Shantsila E; Watson T; Lip GY
    Thromb Res; 2007; 119(5):551-4. PubMed ID: 17010411
    [No Abstract]   [Full Text] [Related]  

  • 12. Novel platelet inhibitors.
    Bennett JS
    Annu Rev Med; 2001; 52():161-84. PubMed ID: 11160773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function testing in cardiovascular diseases.
    Michelson AD
    Circulation; 2004 Nov; 110(19):e489-93. PubMed ID: 15533872
    [No Abstract]   [Full Text] [Related]  

  • 14. Aspirin resistance in the era of personalized medicine: Should we not take it personally?
    Naimo PS; McGiffin D; Konstantinov IE
    J Thorac Cardiovasc Surg; 2015 Dec; 150(6):e99-100. PubMed ID: 26463652
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in antiplatelet therapy for patients with cardiovascular disease.
    Bates ER; Lau WC
    Circulation; 2005 May; 111(17):e267-71. PubMed ID: 15867186
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet glycoprotein IIIa pl(a) polymorphism and effects of aspirin on thrombin generation.
    Szczeklik A; Sanak M; Undas A
    Circulation; 2001 Feb; 103(6):E33-4. PubMed ID: 11171808
    [No Abstract]   [Full Text] [Related]  

  • 18. [Variations in glycoprotein IIb-IIIa (alphaIIb/beta3-integrin) content in healthy donors. Influence on platelet aggregation activity and efficacy of aspirin action].
    Khaspekova SG; Sirotkina OV; Shimanova IuV; Mazurov AV
    Biomed Khim; 2008; 54(3):361-71. PubMed ID: 18712091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aspirin resistance theory].
    Porosińska A; Pierzchała K
    Neurol Neurochir Pol; 2006; 40(4):313-9. PubMed ID: 16967353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.